Latest filing published 09 Jun 2021 for Reata Pharmaceuticals INC.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Elaine Castellanos: trading record in brief
Elaine Castellanos (senior executive) discloses dealings in Reata Pharmaceuticals Inc to SEC (Form 4). Over a trading history stretching from 1 June 2016 to 9 June 2021, the count stands at 43 filings.
The open-market record consists of 21 sales worth €8.3M, with no purchase. 2021 to date brings no purchases and 5 sales.
The record was last updated on 9 June 2021 with an open-market sale (€109k) in Reata Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Elaine Castellanos
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,546 sharesClass A common stockSEC:0001209191-21-039175:0
- 10,000 sharesClass A common stockSEC:0001209191-21-036326:0
2 of 2 declarations
